Overview
Jean-Michel Longtin is the founder and managing director of odyscience, which he established in July 2000 and continues to lead. He is based in Liège. Since September 2024 he has also been at SA Trasis, where he heads the Hospital business unit as vice-president.
Before founding odyscience, Longtin was a project manager at Warner Lambert from 1998 to 2000, and a product manager at MSD from 1995 to 1998.
Career history
- FounderODYSCIENCE
In the news
- Plenty of opportunities to connect by the end of the year. Our teams will be attending seven events across the United States, Europe and North Africa in November and December. Here's where you can meet us: 📍 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 🔹SNMMI Theranostics Conference | November 4-7 | Bethesda, USA | Emmanuel (Manu) Bertrand, David Starr & Elena Parkhomenko 🔹Radiopharma Facility Design, Engineering and Construction Summit | November 18-19 | Indianapolis, USA | Emmanuel (Manu) Bertrand & David Starr 🔹NVNG Autumn Congress 2026 | November 20
- Four days in Vienna, and what days they were! EANM’26 was a truly special edition for Trasis, and we owe it to all of you. Beyond the booth, our side events brought the community together: 🔹 Partner Meeting: 20+ distributors from around the world, aligned on the year ahead 🔹 Community Meeting: 100+ radiochemists, radiopharmacists, physicians and industry experts, with inspiring talks from Memorial Sloan Kettering Cancer Center, St. Olavs hospital, Trondheim University Hospital, Médecine Nucléaire Tourangelle and Trasis 🔹
- Day one of EANM, and the Trasis team is here, fit and well, and full of energy! Ready to showcase our solutions and how, together, they bring a concrete answer at every stage of a radiopharmaceutical’s journey, from the first molecule at the bench to the dose that reaches the patient. We’re looking forward to meeting you, hear about your projects and connect with the people moving nuclear medicine forward. Come say hello at booth 528! Prefer to plan ahead? Send us a DM and we’ll find a time. https://lnkd.in/e8qkFcwJ European
- A few recent stops, a lot of good conversations. From RIV to CSNM, TERACHEM, CSH and Nordic Life Sience, our teams have been on the road meeting radiopharmacy and nuclear medicine professionals across Europe. Thank you to everyone who stopped by, shared a project, asked a question or simply took the time to talk with us. And thank you to Thomas Vergote, PhD, Hugo Andre, Simon Degueldre, Michel Bagoly, Jean-Michel Longtin and Pascal Simoens for representing Trasis along the way. A few moments from the past weeks 👇
- Merci à toutes celles et ceux qui sont venus nous rencontrer aux 21ème Rencontres Convergences Santé Hôpital CSH. Ce fut un plaisir d’échanger avec la communauté de la médecine nucléaire, de discuter des enjeux actuels et de présenter nos solutions dédiées aux workflows hospitaliers, de la préparation des doses au contrôle qualité et à la radioprotection. Et un grand merci à toutes les personnes qui ont pris le temps de venir rencontrer Jean-Michel Longtin et de partager leurs projets. À bientôt ! Dr. solange lao Dr. Fabienne
- 𝗔 𝗽𝗿𝗼𝗺𝗶𝘀𝗶𝗻𝗴 𝗿𝗮𝗱𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗶𝘀 𝗼𝗻𝗹𝘆 𝘁𝗵𝗲 𝗯𝗲𝗴𝗶𝗻𝗻𝗶𝗻𝗴. Bringing a radiopharmaceutical from concept to patients is not a single challenge. It's a sequence of them and they evolve rapidly. Early on, speed is critical. Rapid access to R&D-grade API precursors, radiochemistry development, and data you can trust. This is where months are won or lost. Later, new challenges emerge: reproducibility, automation, GMP manufacturing, multisite transfer, regulatory dossiers, industrial scalability.
- Trasis participera aux 21èmes Rencontres Convergences Santé Hôpital CSH du 22 au 25 septembre à Antibes Juan-les-Pins, au stand 16. Jean-Michel Longtin sera sur place pour présenter nos solutions dédiées à la médecine nucléaire hospitalière, les workflows PET et SPECT, la préparation des doses, le contrôle qualité et la radioprotection. À découvrir sur notre stand : • Unidose, notre système de dispensation pour les hôpitaux, permettant la préparation automatisée des doses et leur injection au patient • LME, notre enceinte
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.